N
ASMB icon

Nuveen’s Assembly Biosciences ASMB Stock Holding History

Nuveen’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-17,630
Closed -$973K – 3363
2021
Q1 		$973K Sell
17,630
-95
-0.5% -$6.3K ﹤0.01% 2890
2020
Q4 		$1.29M Sell
17,725
-9,398
-35% -$1.1M ﹤0.01% 2712
2020
Q3 		$5.35M Sell
27,123
-8,687
-24% -$2.19M ﹤0.01% 1880
2020
Q2 		$10M Sell
35,810
-5,999
-14% -$1.4M ﹤0.01% 1487
2020
Q1 		$7.44M Buy
41,809
+12,449
+42% +$2.67M ﹤0.01% 1478
2019
Q4 		$7.21M Buy
29,360
+11,305
+63% +$2.08M ﹤0.01% 1786
2019
Q3 		$2.13M Sell
18,055
-4,684
-21% -$709K ﹤0.01% 2367
2019
Q2 		$3.68M Buy
+22,739
New +$4.32M ﹤0.01% 2152

Other funds holding ASMB

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Nuveen's ASMB Position: Q2 2021 in Review

Nuveen sold out of Assembly Biosciences (ASMB) in Q2 2021, closing a stake of 17,630 shares — an estimated $973K sold.

Nuveen first reported a position in ASMB in Q2 2019 and held it in 8 quarters. The position peaked at $10M in Q2 2020. 91 funds tracked by Wall St. Rank hold ASMB as of Q2 2021.

  • Nuveen reported no remaining Assembly Biosciences position as of Q2 2021 after selling out during the quarter.
  • Nuveen sold 17,630 Assembly Biosciences shares in Q2 2021, an estimated $973K.
  • Nuveen first reported a position in Assembly Biosciences in Q2 2019 and held it in 8 quarters.
  • Nuveen's Assembly Biosciences position peaked at $10M in Q2 2020.
  • 91 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2021.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.